Literature DB >> 88955

Acycloguanosine: antiviral activity in the rabbit cornea.

M G Falcon, B R Jones.   

Abstract

We describe experiments, using the multiple microinoculation technique, to produce superficial herpes simplex keratitis in the rabbit cornea, which showed a potent antiviral effect of acycloguanosine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88955      PMCID: PMC1043502          DOI: 10.1136/bjo.63.6.422

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  THERAPEUTIC CONSIDERATIONS IN OCULAR VACCINIA.

Authors:  B R JONES; M K AL-HUSSAINI
Journal:  Trans Ophthalmol Soc U K       Date:  1963

2.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

4.  Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy.

Authors:  M G Falcon; B R Jones
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

5.  Antivirals for the therapy of herpetic eye disease.

Authors:  M G Falcon; B R Jones
Journal:  Trans Ophthalmol Soc U K       Date:  1977-07

6.  Treatment of experimental herpes simplex keratitis with acycloguanosine.

Authors:  D J Bauer; P Collins; W E Tucker; A W Macklin
Journal:  Br J Ophthalmol       Date:  1979-06       Impact factor: 4.638

7.  Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers.

Authors:  B R Jones; D J Coster; P N Fison; G M Thompson; L M Cobo; M G Falcon
Journal:  Lancet       Date:  1979-02-03       Impact factor: 79.321

  7 in total
  7 in total

1.  Comparative in vitro imunotoxicology of acyclovir and other antiviral agents.

Authors:  R W Steele; D J Marmer; R E Keeney
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

2.  A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis.

Authors:  D J Coster; K R Wilhelmus; R Michaud; B R Jones
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

3.  Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers.

Authors:  J McGill; P Tormey; C B Walker
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

4.  Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice.

Authors:  K K Biron; J E Noblin; P de Miranda; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

5.  Acyclovir treatment in stromal herpetic keratitis.

Authors:  J A Oosterhuis; R van Ganswijk; J Versteeg
Journal:  Doc Ophthalmol       Date:  1983-12-15       Impact factor: 2.379

6.  Acyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbits.

Authors:  S E Sicher; J O Oh
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

Review 7.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.